Amgen Inc. (AMGN)

NASDAQ: AMGN · IEX Real-Time Price · USD
250.86
+1.16 (0.46%)
At close: Aug 19, 2022 4:00 PM
249.90
-0.96 (-0.38%)
After-hours: Aug 19, 2022 4:41 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012
Revenue
25,97925,42423,36223,74722,84922,99121,66220,06318,67617,265
Revenue Growth (YoY)
2.18%8.83%-1.62%3.93%-0.62%6.13%7.97%7.43%8.17%10.80%
Cost of Revenue
6,4546,1594,3564,1014,0694,1624,2274,4223,3463,199
Gross Profit
19,52519,26519,00619,64618,78018,82917,43515,64115,33014,066
Selling, General & Admin
5,3685,7305,1505,3324,8705,0624,8464,6995,1844,814
Research & Development
4,8194,2074,1163,7373,5623,8404,0704,2974,0833,380
Other Operating Expenses
1,6991896631437513349454196295
Operating Expenses
11,88610,1269,3329,3838,8079,0358,9659,4509,4638,489
Operating Income
7,6399,1399,67410,2639,9739,7948,4706,1915,8675,577
Interest Expense / Income
1,1971,2621,2891,3921,3041,2601,0951,0711,0221,053
Other Expense / Income
-259-256-753-674-928-629-603-465-420-485
Pretax Income
6,7018,1339,1389,5459,5979,1637,9785,5855,2655,009
Income Tax
8088691,2961,1517,6181,4411,039427184664
Net Income
5,8937,2647,8428,3941,9797,7226,9395,1585,0814,345
Net Income Common
5,8937,2647,8428,3941,9797,7226,9395,1585,0814,345
Net Income Growth
-18.87%-7.37%-6.58%324.15%-74.37%11.28%34.53%1.52%16.94%17.97%
Shares Outstanding (Basic)
570586605661731748758759753775
Shares Outstanding (Diluted)
573590609665735754766770765787
Shares Change
-2.88%-3.12%-8.42%-9.52%-2.52%-1.57%-0.52%0.65%-2.79%-13.71%
EPS (Basic)
10.3412.4012.9612.702.7110.329.156.806.755.61
EPS (Diluted)
10.2812.3112.8812.622.6910.249.066.706.645.52
EPS Growth
-16.49%-4.42%2.06%369.15%-73.73%13.02%35.22%0.90%20.29%36.63%
Free Cash Flow Per Share
14.7016.8814.1015.9714.3812.8612.4210.857.466.70
Dividend Per Share
7.0406.4005.8005.2804.6004.0003.1602.4401.8801.440
Dividend Growth
10.00%10.35%9.85%14.78%15.00%26.58%29.51%29.79%30.56%157.14%
Gross Margin
75.20%75.80%81.40%82.70%82.20%81.90%80.50%78.00%82.10%81.50%
Operating Margin
29.40%35.90%41.40%43.20%43.60%42.60%39.10%30.90%31.40%32.30%
Profit Margin
22.70%28.60%33.60%35.30%8.70%33.60%32.00%25.70%27.20%25.20%
Free Cash Flow Margin
32.30%38.90%36.50%44.50%46.00%41.80%43.40%41.10%30.10%30.10%
Effective Tax Rate
12.06%10.68%14.18%12.06%79.38%15.73%13.02%7.65%3.49%13.26%
EBITDA
11,29612,99612,63312,88312,85612,52811,1818,7487,5737,150
EBITDA Margin
43.50%51.10%54.10%54.30%56.30%54.50%51.60%43.60%40.50%41.40%
Depreciation & Amortization
3,3983,6012,2061,9461,9552,1052,1082,0921,2861,088
EBIT
7,8989,39510,42710,93710,90110,4239,0736,6566,2876,062
EBIT Margin
30.40%37.00%44.60%46.10%47.70%45.30%41.90%33.20%33.70%35.10%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).